At Manningham Medical Centre, you can find all the data about Inhibitors Glycogen Synthase Kinase 3 Future Therapy Unmet Medical Needs. We have collected data about general practitioners, medical and surgical specialists, dental, pharmacy and more. Please see the links below for the information you need.


Inhibitors of glycogen synthase kinase-3: Future therapy …

    https://www.researchgate.net/publication/232078204_Inhibitors_of_glycogen_synthase_kinase-3_Future_therapy_for_unmet_medical_needs
    Glycogen synthase kinase-3 (GSK-3) has recently emerged, in the field of medicinal chemistry, as one of the most attractive …

Inhibitors of glycogen synthase kinase-3: future therapy …

    https://www.semanticscholar.org/paper/Inhibitors-of-glycogen-synthase-kinase-3%3A-future-Dorronsoro-Castro/6670152eafcd1c69327fadf7839fa5e0b6876f0f
    Glycogen synthase kinase-3 (GSK-3) has recently emerged, in the field of medicinal chemistry, as one of the most attractive therapeutic targets for the development of …

Glycogen synthase kinase-3 and its inhibitors: Potential …

    https://pubmed.ncbi.nlm.nih.gov/29306837/
    Glycogen synthase kinase-3 and its inhibitors: Potential target for various therapeutic conditions. Glycogen Synthase Kinase-3 (GSK-3) is a serine/threonine …

Inhibitors of glycogen synthase kinase-3: future …

    https://www.researchgate.net/profile/Ana-Martinez-119/publication/232078204_Inhibitors_of_glycogen_synthase_kinase-3_Future_therapy_for_unmet_medical_needs/links/0fcfd51164ec82a3f7000000/Inhibitors-of-glycogen-synthase-kinase-3-Future-therapy-for-unmet-medical-needs.pdf
    Glycogen synthase kinase-3 (GSK-3) was cloned in 1990 and is a key regulator of glycogen synthase, one of the principal modulators of glycogen metabolism and hence …

Mechanisms and Therapeutic Implications of GSK-3 in …

    https://pubmed.ncbi.nlm.nih.gov/33572709/
    Abstract. Neurodegenerative disorders are spreading worldwide and are one of the greatest threats to public health. There is currently no adequate therapy for these …

Activator or inhibitor? GSK-3 as a new drug target

    https://pubmed.ncbi.nlm.nih.gov/23643839/
    Glycogen synthase kinase-3 (GSK-3) is a cytoplasmic serine/threonine protein kinase that phosphorylates and inhibits glycogen synthase, thereby inhibiting glycogen …

Glycogen synthase kinase 3: an emerging therapeutic …

    https://pubmed.ncbi.nlm.nih.gov/11879773/
    It has been implicated in multiple cellular processes and linked with the pathogenesis of several diseases. GSK-3 inhibitors might prove useful as therapeutic compounds in the …

[PDF] Glycogen synthase kinase 3 (GSK-3) inhibitors: a …

    https://www.semanticscholar.org/paper/Glycogen-synthase-kinase-3-%28GSK-3%29-inhibitors%3A-a-Palomo-Mart%C3%ADnez/d95589b090e4e12ab2b1f83d67622ed3f06f31ea
    [PDF] Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2014-2015) | Semantic Scholar GSK-3 inhibitors have gained a prominent role in …

Inhibitors of glycogen synthase kinase-3: future therapy …

    https://www.wikidata.org/wiki/Q60414773
    Inhibitors of glycogen synthase kinase-3: future therapy for unmet medical needs? (Q60414773)

GSK3 Inhibitors in the Therapeutic Development of …

    https://pubmed.ncbi.nlm.nih.gov/28714403/
    GSK3 has gained a considerable attention of researchers in the late 1970s as an inevitable drug target to treat diabetes. Furthermore, it was found to have a key role …



Need more information about Inhibitors Glycogen Synthase Kinase 3 Future Therapy Unmet Medical Needs?

At Manningham Medical Centre, we collected data on more than just Inhibitors Glycogen Synthase Kinase 3 Future Therapy Unmet Medical Needs. There is a lot of other useful information. Visit the related pages or our most popular pages. Also check out our Doctors page.